- Editorial for JUO 2024 Vol. 22 No. 3 - Rethinking Urologic Oncology Surgery
-
Kwak C
- KMID: 2561829
- J Urol Oncol.
- 2024 Nov;22(3):185-187.
- doi: 10.22465/juo.24edi003
-
- CITED
-
- Close
- SHARE
-
- Close
- Correction: Addendum of Informed Consent Statements
-
Editorial Office, Korean Urological Oncology Society
- KMID: 2561840
- J Urol Oncol.
- 2024 Nov;22(3):281-281.
- doi: 10.22465/juo.2024.err03
-
- CITED
-
- Close
- SHARE
-
- Close
- Expression of Concern: Rare Ewingoid Dedifferentiated Liposarcoma of the Spermatic Cord Causing Testicular Artery Compression: A Case Report
-
Editorial Office, Korean Urological Oncology Society
- KMID: 2561841
- J Urol Oncol.
- 2024 Nov;22(3):282-282.
- doi: 10.22465/juo.2024.concern04
-
- CITED
-
- Close
- SHARE
-
- Close
- Trimodal Therapy in the Treatment of Muscle-Invasive Bladder Cancer
-
Jo Y, Yuk HD
- KMID: 2561838
- J Urol Oncol.
- 2024 Nov;22(3):256-267.
- doi: 10.22465/juo.244801000050
This review examines the evolution, clinical efficacy, and future directions of trimodal therapy (TMT) as a bladder-preserving treatment option for muscle-invasive bladder cancer. A nonsystematic literature search was conducted on... -
- CITED
-
- Close
- SHARE
-
- Close
- Exploring the Evolving Role of Metastasectomy in Advanced Renal Cell Carcinoma
-
Kwon J, Bang S, Cho KS
- KMID: 2561835
- J Urol Oncol.
- 2024 Nov;22(3):228-236.
- doi: 10.22465/juo.244800980049
In the treatment of metastatic lesions in advanced renal cell carcinoma (RCC), no clear consensus exists regarding whether immunotherapy should be combined with surgical resection or metastasectomy. Systemic therapies have... -
- CITED
-
- Close
- SHARE
-
- Close
- The Current Role of Metastasis-Directed Therapy for Oligometastatic Renal Cell Carcinoma
-
Kim HJ
- KMID: 2561834
- J Urol Oncol.
- 2024 Nov;22(3):224-227.
- doi: 10.22465/juo.244800960048
Approximately 20% of newly diagnosed renal cell carcinoma (RCC) cases exhibit synchronous metastases, while 20% to 40% of initially localized RCC cases subsequently develop distant metastases after surgical intervention. In... -
- CITED
-
- Close
- SHARE
-
- Close
- Artificial Intelligence: The Latest Advances in the Diagnosis of Bladder Cancer
-
Singh S, Shukla RM
- KMID: 2561839
- J Urol Oncol.
- 2024 Nov;22(3):268-280.
- doi: 10.22465/juo.244800540027
Bladder cancer remains a significant health challenge. Early and accurate diagnoses are crucial for effective treatment and improved patient outcomes. In recent years, artificial intelligence (AI) has emerged as a... -
- CITED
-
- Close
- SHARE
-
- Close
- Early Experience of the Single-Port Robotic Transvesical Radical Prostatectomy: Case Series
-
Chung JH, Kim H, Bang WJ, Oh CY, Cho JS
- KMID: 2561830
- J Urol Oncol.
- 2024 Nov;22(3):188-195.
- doi: 10.22465/juo.244800740037
Purpose: This study evaluated the feasibility and safety of single-port transvesical robotic radical prostatectomy. Materials and Methods: Four patients underwent a transvesical robotic radical prostatectomy using a singleport robotic system. The... -
- CITED
-
- Close
- SHARE
-
- Close
- The Emerging Treatment of BCG (Bacillus Calmette-Guérin)-Unresponsive Non–Muscle-Invasive Bladder Cancer
-
Park JH, Oh JJ
- KMID: 2561837
- J Urol Oncol.
- 2024 Nov;22(3):246-255.
- doi: 10.22465/juo.244800540047
Bacillus Calmette-Guérin (BCG) remains the cornerstone in the treatment of high-risk non-muscle-invasive bladder cancer (NMIBC), effectively preventing recurrence and progression. Unfortunately, a significant proportion of patients are classified as BCG-unresponsive,... -
- CITED
-
- Close
- SHARE
-
- Close
- Clinical Application of Artificial Intelligence-Based Computed Tomography Analysis of Myosteatosis in Localized Renal Cell Carcinoma
-
Kang BJ, Kim KH, Hong SB, Lee NK, Kim S, Kim S, Ha HK
- KMID: 2561836
- J Urol Oncol.
- 2024 Nov;22(3):237-245.
- doi: 10.22465/juo.244800880044
Purpose: Myosteatosis, defined as fat infiltration in muscle tissue, has been linked to poor outcomes in various cancers. However, the prognostic impact of myosteatosis on renal cell carcinoma (RCC) remains... -
- CITED
-
- Close
- SHARE
-
- Close
- Assessing Patient Risk, Benefit, and Outcomes in Drug Development: A Decade of Abiraterone Clinical Trials
-
Rashid M, Oldham E, Hughes GK, Peña AM, Ladd C, Gardner B, McIntire R, Johnson B, Tuia J, Haslam A, Prasad V, Vassar M
- KMID: 2561833
- J Urol Oncol.
- 2024 Nov;22(3):211-223.
- doi: 10.22465/juo.244800520026
Purpose: Our study aimed to evaluate the risk and benefit profiles of clinical trials using abiraterone in cancer treatment. Materials and Methods: A comprehensive search was conducted on May 24, 2023,... -
- CITED
-
- Close
- SHARE
-
- Close
- Simultaneous Prostate Target Biopsy Integrated With Radical Prostatectomy: A Pilot Study Omitting Preoperative Systematic Biopsy
-
Park TY, Hwang JY, Yun SW, Hyun CW, Yoon SG, Kim SB, Noh TI, Shim JS, Park MG, Kang SH, Kang SG
- KMID: 2561831
- J Urol Oncol.
- 2024 Nov;22(3):196-200.
- doi: 10.22465/juo.244800240012
Purpose: This study evaluates the viability of a new method that employs transperineal targeted biopsy with frozen section analysis immediately followed by robot-assisted radical prostatectomy (RARP), bypassing the traditional systematic... -
- CITED
-
- Close
- SHARE
-
- Close
- A Machine Learning Model for Prostate Cancer Prediction in Korean Men
-
Choi S, So B, Oh S, Park H, Lee SW, Song G, Lee JM, Jo JK, Kim SH, Lee SE, Cho EB, Jung JH, Kim JH
- KMID: 2561832
- J Urol Oncol.
- 2024 Nov;22(3):201-210.
- doi: 10.22465/juo.244800400020
Purpose: Unnecessary prostate biopsies for detecting prostate cancer (PCa) should be minimized. Therefore, this study developed a machine learning (ML) model to predict PCa in Korean men and evaluated its... -
- CITED
-
- Close
- SHARE
-
- Close
